NLS Pharmaceutics AG (NLSPW) Stock Analysis

What NLS Pharmaceutics AG does

NLS Pharmaceutics AG is a biopharmaceutical firm currently in its clinical development phase, concentrating on identifying and advancing therapeutic interventions for individuals affected by complex and uncommon conditions impacting the central nervous system (CNS). The company's research and development primarily target narcolepsy, idiopathic hypersomnia, and various other infrequent sleep disorders, alongside neurodevelopmental conditions like attention deficit hyperactivity disorder (ADHD). Key product candidates in their pipeline include Quilience, designed to alleviate excessive daytime drowsiness and cataplexy, and Nolazol, which aims to treat ADHD. Additionally, NLS Pharmaceutics is progressing several other compounds: NLS-4, a selective dopamine reuptake inhibitor for rare sleep disorders; NLS-3, a repurposed methylphenidate ester for ADHD treatment; and NLS-8, a melatonin ML1A receptor agonist that has shown promise in improving scopolamine-induced amnesia. Their portfolio also features NLS-11, a norepinephrine and dopamine reuptake inhibitor with muscarinic M1, M2, M3 receptor antagonist properties, and NLS-12, another norepinephrine and dopamine reuptake inhibitor that functions as a muscarinic M4 receptor antagonist. Established in 2015, NLS Pharmaceutics AG is headquartered in Zurich, Switzerland.

Key metrics

ETFs linked to NLSPW

Broad-market and Healthcare sector ETFs an investor holding NLS Pharmaceutics AG is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how NLSPW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for NLS Pharmaceutics AG?

NLS Pharmaceutics AG trades under the ticker NLSPW on NASDAQ.

Which exchange is NLSPW listed on?

NLSPW is listed on NASDAQ.

What sector does NLS Pharmaceutics AG operate in?

NLS Pharmaceutics AG is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze NLSPW in a portfolio?

PortView shows NLSPW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.